Browsing by Subject Haemophilus Vaccines

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  

Showing results 1 to 15 of 15
bu99-0340.pdf.jpg
Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine / C. Panpitpat ... [et al.]
Panpitpat, Chanatip; Thisyakorn, Usa; Chotpitayasunondh, Tawee; Fürer, Emil; Que, John U; Hasler, Thomas; Cryz, Stanley J ( 2000 )
EUR_ICP_CMDS_94_01_MT03.pdf.jpg
Expanded Programme on Immunization : report on the sixth Meeting of National Programme Managers, Veyrier du Lac France, 23-26 October 1995
Meeting of National EPI Programme Managers (6th: 1995: Veyrier du Lac, France); World Health Organization. Regional Office for Europe ( 1996 )
Abstract

Previously controlled infectious diseases, notably diphtheria and poliomyelitis, are re-emerging in part of the WHO European Region. Epidemic control efforts have been only partially successful, and the Region is now falling behind some other WHO regions in the control of vaccine-preventable infections. The main aims of the Sixth Meeting of European National Programme Managers on the Expanded Programme on Immunization (EPI) were to accelerate progress towards full implementation of national vaccine programmes and to review diphtheria and poliomyelitis control activities. Substantial progress towards poliomyelitis control has been made through Operation MECACAR. In contrast, the diphtheria epidemic in the NIS of the former USSR continues to grow; substantial efforts and resources are now required to bring it under control. Some countries are now implementing hepatitis B and Haemophilus influenzae type b vaccines in the EPI schedule. The strengthening of surveillance systems for vaccine-preventable infections is a high priority for all countries

Global Programme for Vaccines and Immunization (GPV) : the WHO position paper on haemophilus influenzae type b conjugate vaccines
( 1998 )
Haemophilus influenzae type b immunization : introducing Haemophilus influenzae type B (Hib) conjugate vaccine into national immunization services
World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
81(1)61-70.pdf.jpg
Immunization of children at risk of infection with human immunodeficiency virus / William J. Moss, C. John Clements and Neal A. Halsey
Moss, William J; Clements, C. John; Halsey, Neal A ( 2003 )
Inmunización contra Haemophilus influenzae tipo b : introducción de la vacuna conjugada contra Haemophilus influenzae tipo B(Hib) en los servicios nacionales de inmunización
World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
WHO_V-B_00.05_fre.pdf.jpg
Introduction du vaccin anti-Haemophilus influenzae type b dans les programmes de vaccination : principes directeurs pour la gestion et informations à l'intention des agents de santé et des parents
World Health Organization. Dept. of Vaccines and Biologicals ( 2000 )
WHO_V-B_00.05_eng.pdf.jpg
Introduction of Haemophilus Influenzae type b vaccine into immunization programmes : management guidelines, including information for health workers and parents
World Health Organization. Dept. of Vaccines and Biologicals ( 2000 )
Programme mondial des vaccins et vaccinations (GPV) : notes de synthèse : position de l' OMS sur les vaccins conjugués anti-haemophilus influenzae type b
( 1998 )
Report of a meeting on priorities for pneumococcal and Haemophilus influenzae type b (Hib) vaccine development and introduction, Geneva, 9-12 February 1999
World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
Vaccination contre Haemophilus influenzae type b : introduire le vaccin conjugué contre Haemophilus influenzae type B (Hib) dans les services nationaux de vaccination
World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
Vaccine control of Hib disease : reports on individual drugs
( 1998 )
WHO requirements for Haemophilus influenzae type b conjugate vaccines : reports on individual drugs
( 1998 )
Working Group for Economic Evaluation of Pneumococcal and Haemophilus Influenzae Type b Vaccines : report of the first meeting, 19-20 June 2000
Working Group for Economic Evaluation of Pneumococcal and Haemophilus Influenzae Type b Vaccines. Meeting (1st: 2000: Geneva, Switzerland); World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
WHO_V-B_00.05_rus.pdf.jpg
Включение вакцины против Haemophilus influenzae тип b в программы иммунизации: Общее руководство, включая информацию для работников здравоохранения и родителей.
Всемирная организация здравоохранения; Департамент вакцин и биологических препаратов ( 2001 )
Showing results 1 to 15 of 15